AU7228394A - Indoline derivatives as 5HT2C antagonists - Google Patents

Indoline derivatives as 5HT2C antagonists

Info

Publication number
AU7228394A
AU7228394A AU72283/94A AU7228394A AU7228394A AU 7228394 A AU7228394 A AU 7228394A AU 72283/94 A AU72283/94 A AU 72283/94A AU 7228394 A AU7228394 A AU 7228394A AU 7228394 A AU7228394 A AU 7228394A
Authority
AU
Australia
Prior art keywords
indoline
pyridylcarbamoyl
chloro
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72283/94A
Other languages
English (en)
Inventor
Ian Thomson Forbes
Peter Ham
Graham Elgin Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU7228394A publication Critical patent/AU7228394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Eyeglasses (AREA)
AU72283/94A 1993-07-06 1994-06-30 Indoline derivatives as 5HT2C antagonists Abandoned AU7228394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939313913A GB9313913D0 (en) 1993-07-06 1993-07-06 Novel compounds
GB9313913 1993-07-06
PCT/EP1994/002148 WO1995001976A1 (en) 1993-07-06 1994-06-30 Indoline derivatives as 5ht2c antagonists

Publications (1)

Publication Number Publication Date
AU7228394A true AU7228394A (en) 1995-02-06

Family

ID=10738344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72283/94A Abandoned AU7228394A (en) 1993-07-06 1994-06-30 Indoline derivatives as 5HT2C antagonists

Country Status (15)

Country Link
US (1) US5834494A (https=)
EP (1) EP0707581B1 (https=)
JP (1) JPH08512299A (https=)
CN (1) CN1129937A (https=)
AP (1) AP463A (https=)
AT (1) ATE149163T1 (https=)
AU (1) AU7228394A (https=)
CA (1) CA2166624A1 (https=)
DE (1) DE69401823T2 (https=)
GB (1) GB9313913D0 (https=)
IL (1) IL110204A0 (https=)
MA (1) MA23254A1 (https=)
TW (1) TW297023B (https=)
WO (1) WO1995001976A1 (https=)
ZA (1) ZA944807B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
EP0807104A2 (en) * 1995-02-02 1997-11-19 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
DK0808312T3 (da) * 1995-02-02 2001-02-12 Smithkline Beecham Plc Indolderivater som 5-HT-receptorantagonist
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
AU2759597A (en) * 1996-05-16 1997-12-05 Allelix Biopharmaceuticals Inc. Thiophene- and furan-tryptamine derivatives
GB9612883D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
US6453357B1 (en) 1999-01-07 2002-09-17 Cisco Technology, Inc. Method and system for processing fragments and their out-of-order delivery during address translation
WO2000076984A2 (en) * 1999-05-21 2000-12-21 Biovitrum Ab Novel compounds, their use and preparation
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2810979B1 (fr) * 2000-06-29 2002-08-23 Adir Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
DE60100294T2 (de) * 2001-07-09 2003-12-11 Alcatel Sel Ag Verbinder für optische Fasern
US6861440B2 (en) 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4460450B2 (ja) 2002-06-19 2010-05-12 ビオヴィトルム・アクチボラゲット(プブリクト) 新規化合物、その使用および製造法
ATE437876T1 (de) 2003-06-20 2009-08-15 Hoffmann La Roche Hexahydropyridoisochinoline als dpp-iv- inhibitoren
WO2005000848A1 (en) 2003-06-20 2005-01-06 F. Hoffmann-La Roche Ag Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
BRPI0616000B1 (pt) * 2005-09-13 2016-04-19 Bayer Cropscience Ag composto derivado de fenil-amidina, processo de preparação de composto, composto derivado de nitrofeniléter, composto derivado de aminofeniléter, método de controle de fungos fitopatogênicos de safras e método de controle de insetos daninhos.
US9052304B2 (en) 2009-03-13 2015-06-09 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
CN106278987A (zh) * 2016-08-16 2017-01-04 都创(上海)医药科技有限公司 吲哚啉类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428881A (en) * 1977-12-23 1984-01-31 Gulf Oil Corporation Control of unwanted vegetation with N-carbamylindolines
IE913204A1 (en) * 1990-09-13 1992-02-25 Beecham Group Plc Novel compounds
EP0656003A1 (en) * 1992-08-20 1995-06-07 Smithkline Beecham Plc Condensed indole derivatives as 5ht2c and 5ht2b antagonists

Also Published As

Publication number Publication date
US5834494A (en) 1998-11-10
DE69401823D1 (de) 1997-04-03
CN1129937A (zh) 1996-08-28
AP463A (en) 1996-02-19
ATE149163T1 (de) 1997-03-15
IL110204A0 (en) 1995-01-24
EP0707581A1 (en) 1996-04-24
TW297023B (https=) 1997-02-01
MA23254A1 (fr) 1995-04-01
EP0707581B1 (en) 1997-02-26
CA2166624A1 (en) 1995-01-19
DE69401823T2 (de) 1997-08-28
JPH08512299A (ja) 1996-12-24
WO1995001976A1 (en) 1995-01-19
ZA944807B (en) 1996-01-04
GB9313913D0 (en) 1993-08-18
AP9400653A0 (en) 1994-07-31

Similar Documents

Publication Publication Date Title
EP0707581B1 (en) Indoline derivatives as 5ht2c antagonists
CN101243068B (zh) 治疗多重耐药性细菌感染的化合物
CN1064358C (zh) 苄基哌啶衍生物
KR950010163B1 (ko) 신규 인돌 유도체
AU727608B2 (en) CBI analogs of CC-1065 and the duocarmycins
EP0690843B1 (en) Formyl- or cyano- substituted indole derivatives having dopaminergic activity
WO2003013510A1 (en) 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
EP1216239A1 (en) Piperazine derivatives as 5-ht1b antagonists
WO2008047831A1 (en) Jak inhibitor
US20040102418A1 (en) Compounds for the treatment of inflammatory disorders
KR20070114123A (ko) 염증 치료에 유용한 인돌
JPH0784462B2 (ja) ベンゾイミダゾ−ル誘導体
HU221193B1 (en) Neuroprotective indole, qinoline and benzoxazolone derivatives, pharmaceutical compositions comprising such compounds and process for producing them
FR2804114A1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
CN1227841A (zh) 作为5-ht1a拮抗剂的哌嗪衍生物
CN101351446A (zh) 新的稠合吡咯衍生物
AU2006237920A1 (en) Nitrogen-containing heterocyclic compound
FR2805536A1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
EP1487801A1 (en) 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
JPWO1998000400A1 (ja) テトラヒドロベンズインドール化合物
KR20070061569A (ko) Cns 장애 치료를 위한 5-ht6 수용체 길항제로서의5-술포닐-1-피페리디닐 치환된 인돌 유도체
CN107108575A (zh) 作为抗组胺剂的新型苯并咪唑衍生物
JPWO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
KR100517387B1 (ko) 벤젠술폰아미드 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
CN1222152A (zh) 用作5-ht-2c受体拮抗剂的二氢吲哚衍生物